Actively Recruiting

Phase 4
Age: 18Years - 60Years
All Genders
Healthy Volunteers
NCT06041048

Investigation of Locus Coeruleus Function in Sustained Attention

Led by University of California, Davis · Updated on 2025-12-12

40

Participants Needed

1

Research Sites

117 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The norepinephrine-producing locus coeruleus (LC) is thought to be central to a wide array of cognitive functions, like attention and goal pursuit, and has been implicated in dysfunctions including attention deficit hyperactivity disorder and schizophrenia. The goal of this proposal is to develop methods that permit measurement of activity in the human LC. Because the LC is small and located in the pons, the Investigators will use high resolution magnetic resonance imaging techniques tailored to the brainstem environment, including neuromelanin-sensitive images shown to delineate the LC, combined with pharmacological manipulation to confirm the location of functional activity.

CONDITIONS

Official Title

Investigation of Locus Coeruleus Function in Sustained Attention

Who Can Participate

Age: 18Years - 60Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Between the ages of 18 - 60 years of age
  • Typically developing, healthy adult
Not Eligible

You will not qualify if you...

  • History of schizophrenia, other forms of psychosis
  • Specific or focal neurological disorder or severe alcohol or drug use disorder within the past 5 years
  • History of left ventricular hypertrophy or mitral valve prolapse syndrome related to CNS stimulants, or recent myocardial infarction or unstable angina
  • Known hypersensitivity or allergy to modafinil, armodafinil, or their inactive ingredients
  • Inability to swallow tablets or tolerate oral medication
  • Pregnant or nursing (negative pregnancy test required)
  • Contraindications for MRI scanning such as metal implants, pacemakers, metal foreign bodies, or pregnancy
  • Use of psychotropic medication within the past week
  • Claustrophobia or discomfort with small spaces

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of California, Davis

Sacramento, California, United States, 95817

Actively Recruiting

Loading map...

Research Team

J

Julie Schweitzer, PhD

CONTACT

J

Jared Borden, MA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here